Delivery Order SPE2DB24D1205-SPE2DB25FCQQA
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,695.58 firm-fixed-price contract is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract has a June 4, 2025 ultimate completion date. AmerisourceBergen Drug Corp is delivering the medication under a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,949.78 firm fixed-price contract is for the supply of 4568143553 - RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp, a for-profit corporate entity, is the prime contractor and does not have any identified subcontractors....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,402.66, is for the delivery of RINVOQ ER 45 MG TABLET UU 28S medical supplies. The contract is a firm fixed price arrangement with a completion date of May 23, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,595.91 firm fixed-price contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a medication used to treat certain medical conditions. The contract has an ultimate completion date of March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,092.28, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a ceiling value of $36,092.52 and an ultimate completion date of September 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by federal agencies, including a...
- This federal contract award, valued at $26,492.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a medication, and has a completion date of February 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $17,099.61 firm-fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of September 5, 2024. This award is a task order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,472.57 firm fixed-price delivery order is for the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,918.35, is for the delivery of the pharmaceutical product RINVOQ ER 45 MG TABLET UU 28S. It is a Firm Fixed Price contract with a period of performance ending on May 23, 2025. The contract is not set aside, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCQQADelivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $66,782.90 firm fixed-price contract is for the supply of the pharmaceutical product RINVOQ ER 45 MG TABLET UU 28S. The contract has an ultimate completion date of October 9, 2024. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to various federal agencies and healthcare programs, including the military, through its extensive federal contract portfolio. This delivery order is likely part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $66.8k | 10/8/24 |